26 related articles for article (PubMed ID: 33049467)
1. Evaluation of in vitro dissolution profiles of modified-release metoprolol succinate tablets crushed using mortar and pestle technique.
Kir F; Al-Sulaiti FK; Sahin S
Eur J Pharm Sci; 2024 Mar; 194():106694. PubMed ID: 38191064
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Discriminative Dissolution Medium for a Poorly Soluble Nutraceutical Tetrahydrocurcumin.
Shiek Abdul Kadhar Mohamed Ebrahim HR; Chungath TT; Sridhar K; Siram K; Elumalai M; Ranganathan H; Muthusamy S
Turk J Pharm Sci; 2021 Oct; 18(5):565-573. PubMed ID: 34719154
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of spectrophotometric method for simultaneous estimation of paracetamol and lornoxicam in different dissolution media.
Patel DM; Sardhara BM; Thumbadiya DH; Patel CN
Pharm Methods; 2012 Jul; 3(2):98-101. PubMed ID: 23781487
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous estimation of two anti-diabetic drugs; Linagliptin and empagliflozin in their tablet by chemometric spectrophotometry.
Kamal AH; Hammad SF; Salim MM; Elkhodary MM; Marie AA
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jan; 305():123556. PubMed ID: 37866257
[TBL] [Abstract][Full Text] [Related]
5.
Dongala T; Katari NK; Ettaboina SK; Krishnan A; Tambuwala MM; Dua K
Front Mol Biosci; 2020; 7():613393. PubMed ID: 33521056
[TBL] [Abstract][Full Text] [Related]
6. A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia.
Dongala T; Ettaboina SK; Katari NK
Res Sq; 2020 May; ():. PubMed ID: 32702733
[TBL] [Abstract][Full Text] [Related]
7. Method Development for Simultaneously Determining Indomethacin and Nicotinamide in New Combination in Oral Dosage Formulations and Co-Amorphous Systems Using Three UV Spectrophotometric Techniques.
Sarkis N; Sawan A
Int J Anal Chem; 2024; 2024():2035824. PubMed ID: 38414841
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Evaluation of Cefuroxime Axetil Tablets Available in Drug Market of Pakistan.
Israr F; Mahmood ZA; Hassan F; Hasan SM
Indian J Pharm Sci; 2016; 78(1):17-26. PubMed ID: 27168677
[TBL] [Abstract][Full Text] [Related]
9. Time-Lapse Macro Imaging with Dissolution Tests for Exploring the Interrelationship Between Disintegration and Dissolution Behaviors of Solid Dosages.
Yang Y; Gengji J; Gong T; Zhang Z; Deng L
Pharm Res; 2024 Feb; 41(2):387-400. PubMed ID: 38243127
[TBL] [Abstract][Full Text] [Related]
10. Three new, UV spectrum filtration protocols for the synchronous quantification of ciprofloxacin HCl and ornidazole in the existence of ciprofloxacin-induced degradation compound.
Sakur AA; Zakri DA
Heliyon; 2023 Dec; 9(12):e22752. PubMed ID: 38213591
[TBL] [Abstract][Full Text] [Related]
11. Transfer of drug dissolution testing by statistical approaches: Case study.
Al-Kamarany MA; El Karbane M; Ridouan K; Alanazi FK; Hubert P; Cherrah Y; Bouklouze A
Saudi Pharm J; 2012 Jan; 20(1):93-101. PubMed ID: 24109204
[TBL] [Abstract][Full Text] [Related]
12. Univariate versus multivariate spectrophotometric data analysis of triamterene and xipamide; a quantitative and qualitative greenly profiled comparative study.
Abd El-Hadi HR; Eissa MS; Zaazaa HE; Eltanany BM
BMC Chem; 2023 May; 17(1):47. PubMed ID: 37179391
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of a ternary mixture of doxylamine succinate, pyridoxine hydrochloride, and folic acid by the ratio spectra-zero-crossing, double divisor-ratio spectra derivative, and column high-performance liquid chromatographic methods.
Pathak A; Rajput SJ
J AOAC Int; 2008; 91(5):1059-69. PubMed ID: 18980119
[TBL] [Abstract][Full Text] [Related]
14. Comparative dissolution profiles of two anti-emetic delayed release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules.
Alcocer C; Iraola M; Rom E; Hoarau D; Gergic E; Perez de la Cruz MA; Regidor PA
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4420-4430. PubMed ID: 35776043
[TBL] [Abstract][Full Text] [Related]
15. Chemometric Quality Assessment of Doxylamine Succinate With Its Degradation Product: Implementation of Two Predictive Models on UV-Spectrophotometric Data of Anti-Emetic Binary Mixture.
Abd El-Hadi HR; Eissa MS; Zaazaa HE; Eltanany BM
J AOAC Int; 2022 Dec; 106(1):221-227. PubMed ID: 35904581
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of pyridoxine hydrochloride and doxylamine succinate from tablets by ion pair reversed-phase high-performance liquid chromatography (RP-HPLC).
Argekar AP; Sawant JG
Drug Dev Ind Pharm; 1999 Aug; 25(8):945-50. PubMed ID: 10434138
[TBL] [Abstract][Full Text] [Related]
17. Systemic bioavailability and pharmacokinetics of the doxylamine-pyridoxine delayed-release combination (Diclectin).
Gill SK; Garcia-Bournissen F; Koren G
Ther Drug Monit; 2011 Feb; 33(1):115-9. PubMed ID: 21079545
[TBL] [Abstract][Full Text] [Related]
18. In vitro analytical dissolution profiling of antiemetic delayed release tablets in two different dissolution media: Validated spectrophotometric methods versus reported HPLC.
Eltanany BM; Abd El-Hadi HR; Zaazaa HE; Eissa MS
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Feb; 246():119013. PubMed ID: 33049467
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
